Julie Le Naour Selected Research

Neoplasm Antigens (Tumor Antigens)

1/2021

Trial watch: intratumoral immunotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julie Le Naour Research Topics

Disease

13	Neoplasms (Cancer) 01/2023 - 01/2019
3	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 01/2020
2	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2020
2	Squamous Cell Carcinoma of Head and Neck 01/2022 - 01/2020
1	Colitis 01/2023
1	Carcinogenesis 01/2023
1	Breast Neoplasms (Breast Cancer) 01/2023
1	Carcinoma (Carcinomatosis) 01/2023
1	Melanoma (Melanoma, Malignant) 01/2023
1	Ulcerative Colitis 01/2023
1	Fibrosarcoma 01/2023
1	Inflammation (Inflammations) 01/2023
1	Bites and Stings (Sting) 01/2020
1	Infections 01/2020
1	Condylomata Acuminata (Genital Wart) 01/2020
1	Actinic Keratosis 01/2020
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2018

Drug/Important Bio-Agent (IBA)

3	Poly I-CIBA 01/2023 - 01/2020
3	LigandsIBA 01/2023 - 01/2020
3	Peptides (Polypeptides)IBA 01/2023 - 01/2020
3	Pattern Recognition ReceptorsIBA 01/2022 - 01/2020
3	VaccinesIBA 01/2021 - 01/2020
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2023 - 01/2020
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2019
2	AnthracyclinesIBA 01/2021 - 01/2021
2	CytokinesIBA 01/2021 - 01/2020
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2020
2	InterferonsIBA 01/2020 - 01/2020
2	B7-H1 AntigenIBA 01/2020 - 01/2019
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020 - 01/2019
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2023
1	MutagensIBA 01/2023
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2023
1	Toll-Like Receptor AgonistsIBA 01/2023
1	Immunologic Adjuvants (Immunologic Adjuvant)IBA 01/2023
1	cyclosporin HIBA 01/2023
1	AntibodiesIBA 01/2023
1	AzoxymethaneIBA 01/2023
1	Sulindac (Copal)FDA LinkGeneric 01/2023
1	Detergents (Detergent)IBA 01/2023
1	Dextrans (Dextran)FDA Link 01/2023
1	Phenobarbital (Luminal)FDA Link 01/2023
1	PlatinumIBA 01/2022
1	X-Box Binding Protein 1IBA 01/2022
1	Alanine (L-Alanine)FDA Link 01/2022
1	Anesthetics (Anesthetic Agents)IBA 01/2022
1	Local AnestheticsIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Threonine (L-Threonine)FDA Link 01/2022
1	Activating Transcription Factor 4IBA 01/2022
1	Activating Transcription Factor 6IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 10/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2021
1	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 01/2021
1	Annexin A1IBA 01/2021
1	CarcinogensIBA 01/2021
1	VTX-2337IBA 01/2020
1	AntigensIBA 01/2020
1	Mucin-1 (CA 15-3 Antigen)IBA 01/2020
1	Poly A-UIBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Double-Stranded RNA (RNA, Double Stranded)IBA 01/2020
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2020
1	Imiquimod (Aldara)FDA LinkGeneric 01/2020
1	resiquimodIBA 01/2020
1	InterleukinsIBA 01/2020
1	Interferon Type IIBA 01/2020
1	hydroxycitric acidIBA 01/2019
1	Programmed Cell Death 1 ReceptorIBA 01/2019
1	SpermidineIBA 01/2019
1	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2019
1	Immune Checkpoint ProteinsIBA 01/2019
1	DefensinsIBA 10/2018

Therapy/Procedure

6	Drug Therapy (Chemotherapy) 01/2023 - 01/2019
4	Therapeutics 01/2023 - 01/2020
2	Radiotherapy 01/2021 - 01/2020
2	Immunotherapy 01/2021 - 01/2021
1	Chemoradiotherapy 01/2023
1	Caloric Restriction 01/2019